Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01996644 · ClinicalTrials.gov registry record · NA
A Double Blind Clinical Trial of DCS for Food Anxiety
A NA study of Anorexia and Bulimia Nervosa, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
- 1
- Study location
NCT01996644 is a NA study of Anorexia and Bulimia Nervosa that has completed, run by Washington University School of Medicine. The registered enrollment target is 47 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01996644, a NA study of Anorexia and Bulimia Nervosa, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study investigating if cycloserine (DCS; a learning enhancement medication) augments exposure therapy for food anxiety in patients with anorexia and bulimia nervosa. The investigators expect that (a) exposure therapy will reduce anxiety (b) anxiety will be reduced more in the DCS relative to placebo condition (c) participants in the DCS condition will have a greater increase in Body Mass Index.
Conditions Studied
Interventions
- DRUG Placebo vs Setraline
- DRUG Setraline
Study Locations (1)
Missouri
- Washington University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2013-02 |
| Est. Completion | 2014-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01996644
The ClinicalTrials.gov registry entry for NCT01996644 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anorexia and Bulimia Nervosa appearing as the primary indexed condition, and to 2 interventions - of which Placebo vs Setraline is the first listed.
NCT01996644 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT01996644 about?
NCT01996644 is a clinical study titled "A Double Blind Clinical Trial of DCS for Food Anxiety". This is a pilot study investigating if cycloserine (DCS; a learning enhancement medication) augments exposure therapy for food anxiety in patients with anorexia and bulimia nervosa. The investigators expect that (a) exposure therapy will reduce anxiety (b) anxiety will be reduced more in the DCS rel...
What is the current status of trial NCT01996644?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2013-02. Estimated completion is 2014-02.
What conditions does trial NCT01996644 study?
This clinical trial studies the following conditions: Anorexia and Bulimia Nervosa.
What interventions are being tested in trial NCT01996644?
The interventions under investigation include: Placebo vs Setraline (DRUG), Setraline (DRUG).
Who is sponsoring clinical trial NCT01996644?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01996644 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.